Disciplined Equity Management, Inc. Abb Vie Inc. Transaction History

Disciplined Equity Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $68,800 - $77,485	500 New	500 $77,000
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $932,088 - $1.07 Million	-6,945 Reduced 98.44%	110 $15,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $50,919 - $64,735	-370 Reduced 4.98%	7,055 $1.08 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $971,900 - $1.21 Million	-7,364 Reduced 49.79%	7,425 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.59 Million - $2.01 Million	14,789 New	14,789 $2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Disciplined Equity Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Disciplined Equity Management, Inc. with notifications on news.